Refine Your Strategy, Sharpen Your Positioning, & Understand Expectations for Deal Conversations

Whether developing first-in-class degraders, best-in-class TCEs, novel payloads for ADCs, or AI-driven drug discovery platforms to validate new targets, the clinical and competitive challenges in today's landscape demand collaboration with pharma to validate technology, access capital, and leverage infrastructure to achieve Phase 3 success.

Bringing independent Autoimmunity, ADC, TPD, and TCE Partnering Summits into a single arena, the Oncology & Immunology Innovation Partnering & Licensing Summit gathers a critical mass of related discovery technologies and development pipelines.

  • Which stage of development, in detail, are pharma and investors looking for?
  • What data is valuable for pharma to see when not in the clinic?
  • What is a key element of differentiation that a biotech can demonstrate?
  • How much opportunity is there for novel targets?
  • Which targets will be most important in 10 years’ time?

Through a dedicated one-to-one partnering system, organized matchmaking, and total audience alignment, pharma can efficiently meet, provide feedback on, and compare licensing and co-development opportunities, whilst biotech business development can cut through the noise and competition to secure guaranteed meetings with key stakeholders.

Speakers at Oncology & Immunology Innovation Partnering

What are the Sessions?

Pharma Icebreaker Discussion: Insights into Big Pharma’s Wish List

Hear insights into what pharma is looking for directly from business development leads to ensure you share the right information in your private meetings that follow. Does pharma want a lead candidate? What is the key element of differentiation? And what kind of data package is needed to be shown to make a deal? For biotech companies looking to confidently introduce or update their programs, this is a deliberate opportunity for you to understand each pharma’s needs from the outset.

Pharma & Investor Icebreaker Roundtables: Unlock Connections & Break the Ice

Following each pharma and investor panel on the mornings or day one and day two respectively, introduce yourself to attending leaders during the Icebreaker Roundtables. Lay groundwork for follow-up opportunity, ask questions, and hear how other biotech approach conversations when differentiating their pipeline.

One-on-One Partnering System: Schedule Individual Meetings with Other Attendees

Leveraging a one-to-one partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.

Presentation Availability During “Showcase Your Science” Sessions in the Agenda

At the intersection of innovative research and business conversations, this forum supports the pitching of biotech pipelines and platforms to pharma and investors. As you register, secure a 15-minute presentation slot. There will be no conflicting content happening to ensure a full and engaged audience, allowing you generate interest from a large group of potential partners and support any private conversations.

Explore the Full Event Guide

  • 1 to 5 ratio of biotech to pharma and investors
  • 30%+ acceptance rate on meeting platform
  • Pharma and investors present in >50% of meetings
  • Two formal structured networking sessions, one informal drinks reception
  • Refine your strategy, strengthen your pitch, nurture your relationships to stay front-of-mind after BIO and before JPM
Oncology & Immunology Innovation Partnering Brochure Image
Audience at Oncology & Immunology Innovation Partnering

Review the Program

Confidently evaluate if this targeted networking opportunity aligns with your partnering objectives. Review the format, speaker faculty, and remaining presentation sessions in the full event guide.

Networking at Oncology & Immunology Innovation Partnering

Become a Founding Partner

If you’re a law firm, bank, or offer-omics, CRO, or CDMO services and you’re looking for a differentiated and near-exclusive opportunity to associate your brand awareness with high-value interactions, review information about becoming a founding partner here.

Speaker at Oncology & Immunology Innovation Partnering

Register to Join

Bridging the gap between innovative R&D and partnership conversations: deliberately timed between BIO and JPM. Register for early-bird discounts, secure a presentation opportunity whilst they last, and share your company logo with us to advertise your attendance on this website.